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Abstract The ribosomal DNA transcription-speci¢c factor,
UBF, is a key target for the regulation of ribosomal RNA syn-
thesis and hypertrophic growth of isolated neonatal cardiomyo-
cytes. In this study, we have examined whether UBF expression
is also an important determinant of cardiac growth rates in vivo.
We show that rDNA transcription, rRNA synthesis and UBF
expression in left ventricular myocytes isolated from mice 1^
6 weeks following transverse aortic constriction were signi¢-
cantly increased (2.5^3.5-fold) compared to the levels in myo-
cytes from the left ventricle of sham-operated mice.
. 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Growth of cardiac muscle cells during left ventricular hy-
pertrophy (LVH) results from an increased accumulation of
cellular protein due to an accelerated rate of protein synthesis
[1]. Elevated rates of protein synthesis can be achieved by
altering the translational e⁄ciency of existing ribosomes
and/or by accelerating the rate of synthesis of new ribosomes
(increased translational capacity). Recent studies both in vivo
and with isolated myocyte cultures suggest that the hypertro-
phic growth response is biphasic with an initial acute increase
in translational e⁄ciency, followed by an adaptive increase in
translational capacity or rRNA synthesis during sustained in-
creases in growth demand [2^4]. Indeed, accelerated rates of
rRNA synthesis and ribosome accumulation have been dem-
onstrated to accompany increased rates of protein synthesis in
all models of cardiomyocyte hypertrophy in which it has been
examined [5^7]. Furthermore, the increased rate of ribosome
synthesis during K-adrenergic or contraction stimulation of
neonatal cardiomyocytes is required for the increase of pro-
tein synthesis and cell size accompanying the hypertrophic
response [8]. Together these studies suggest a major role for
ribosome biogenesis in the regulation of cardiac growth.
For mammalian cells, a major rate-limiting step in ribo-
some biogenesis is the transcription of the ribosomal 45S
gene (rDNA) by RNA polymerase I [9^11]. One factor that
has been implicated in the regulation of ribosome biogenesis
during cardiomyocyte hypertrophy is the rDNA transcription
factor termed upstream binding factor or UBF (reviewed in
[12^15]). In the context of cardiomyocyte growth, the cellular
amount of UBF correlates strongly with the growth rate of
non-dividing, cultured neonatal cardiomyocytes [5,6,12].
Moreover, direct over-expression of recombinant UBF1, in
the absence of hypertrophic stimulus, is su⁄cient to signi¢-
cantly increase rDNA transcription in neonatal cardiomyo-
cytes [16]. Conversely, inhibition of UBF accumulation via
adenovirus-mediated delivery of UBF antisense RNA pre-
vents increases in rDNA transcription, rRNA accumulation
and protein synthesis during hypertrophic stimulation of neo-
natal cardiomyocytes [8].
One potential shortfall of the above studies is that they
were performed in isolated neonatal cardiomyocyte cultures,
which exhibit many important di¡erences from fully di¡eren-
tiated adult cardiomyocytes in vivo. With respect to ribosome
biogenesis, we have found that the rates of rDNA transcrip-
tion in nuclei isolated from adult cardiomyocytes are approx-
imately one-¢fth of that found in equivalent amounts of nu-
clei isolated from neonatal cardiac myocytes (R. Hannan,
unpublished data). This suggests that alternative regulatory
mechanisms may control rDNA transcription in adult and
neonatal cardiomyocytes. Thus, as a ¢rst step in addressing
the role of UBF expression in the regulation of rDNA tran-
scription and protein synthesis in vivo, we have examined
UBF expression in cardiac myocytes isolated from control
mice and mice undergoing transverse aortic constriction
(TAC)-induced LVH.
2. Materials and methods
2.1. DNA constructs
A 755-bp rat atrial natriuretic peptide (ANP) cDNA, and a 177-bp
rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA
clone (GAPDH-177) used for RNase analysis have been described
previously [17]. The mouse 45S rDNA external transcribed spacer
(ETS) construct (pGEM4z-ETS) used to measure 45S rRNA levels
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by RNase protection assay was prepared from a mouse genomic clone
(pMENA) of the 45S gene [18]. An EcoRI-EcoRI (3640 to +155)
fragment of pMENA was ligated into the EcoRI site of pGEM4z
(Promega) in the antisense direction with respect to the T7 promoter
site. Integrity of the clone was veri¢ed by sequencing.
2.2. Animals, microsurgery and functional determination
Three-month-old male and female mice of C57/SJL crossing were
used. Animals were anesthetized with a mixture of ketamine/xylazine/
atropine (8, 2 and 0.6 mg/100 g, respectively) and the pain reliever
temgesic at 0.1 mg/100 g was given. After tracheal intubation and
mechanical ventilation, a midline incision was made at the upper
sternum. With the aid of a surgical microscope, the transverse aorta
was dissected and then narrowed to a lumen size of 0.4 mm according
to a method previously described [17,19]. Control mice underwent
similar surgery except for the narrowing of the aorta. At the sched-
uled time after surgery, mice were anesthetized again as described
above. A 1.4F micro-tip pressure transducer catheter (Millar Instru-
ments) was inserted into the aorta via the right carotid artery and then
advanced into the left ventricle (LV). Aortic blood pressure and left
ventricular pressure were acquired digitally and averages of measure-
ments from 10 consecutive beats were used.
2.3. Organ weights
Mice were killed by an overdose of pentobarbital. The LV, right
ventricle (RV), and atria were separated and weighed. The lungs and
liver were weighed, and the tibial length was measured.
2.4. Isolation of adult mouse cardiomyocytes
Cannulation of hearts was carried out via the aorta according to the
Langendor¡ method in ice-cold Ca2þ-free, HEPES-bu¡ered Krebs
medium containing 10 mM 2,3-butanedione monoxime, 30 mM tau-
rine, 5 mM creatine and 0.1 IU/ml insulin, as already described [20].
Hearts were perfused with the medium at 2 ml/min in 5-ml organ
baths, kept at 37‡C and gassed constantly with 95% O2/5% CO2.
Collagenase (2 mg/ml) was added to the perfusate and the hearts
perfused in a recirculating manner for 30 min. LV and RV were
then gently dissected apart from the digested hearts in fresh collage-
nase-containing medium and the tissue ¢ltered through coarse nylon
mesh. Myocytes were puri¢ed away from ¢broblasts and other cardiac
non-cardiomyocytes by centrifugation at 100Ug, and gently washed
by resuspension and sedimentation in collagenase-free medium before
¢nal resuspension and sedimentation in phosphate-bu¡ered saline.
Myocytes prepared in this manner were immediately processed for
RNA, DNA and protein analysis without further intervention.
2.5. RNA extraction and ribonuclease protection assays
Total RNA was isolated from adult cardiomyocytes as described
previously [21] at the time points indicated. Plasmids containing rat
ANP cDNA, GAPDH cDNA and a mouse 45S rDNA clone were
used as templates to generate 32P-labeled complementary RNA probes
for hybridization and RNase protection analysis, as described [21].
Following hybridization and RNase digestion, the protected RNA
hybrids were analyzed on denaturing polyacrylamide gels and quan-
titated on a Fuji BAS-1000 phosphorimaging system. Levels of
GAPDH mRNA, simultaneously hybridized with ANP mRNA or
45S ETS rRNA, were used to correct for minor di¡erences in RNA
loading.
2.6. Protein and DNA determination
DNA determinations on cardiomyocytes isolated from LV and RV
were performed by the method of Pederson [22] using herring sperm
DNA as a standard. Protein levels were simultaneously determined in
the same myocyte samples using the Bio-Rad DC assay kit as de-
scribed previously [5,6].
2.7. SDS^PAGE and western analysis
Cell extracts (100 Wg of protein) were resuspended in SDS-sample
bu¡er, boiled and then size-fractionated by sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) (8% gels) and trans-
ferred to Immobilon1-P (Amersham) membranes. The blot was sub-
sequently probed with the indicated antibodies to UBF1/2 [5,8,23,24]
and extracellular signal-regulated kinase (ERK, Santa Cruz, K-23)
and developed using the appropriate secondary antibodies and en-
hanced chemiluminescence (Amersham).
2.8. Statistics
Values are meansRS.E.M. Between-group di¡erences were ana-
lyzed by one-way analysis of variance followed by Fisher’s protected
least signi¢cant di¡erence test for post-hoc comparisons. Signi¢cance
was determined at P6 0.05.
3. Results
3.1. Assessment of pressure overload
Catheterization was performed on mice with TAC or sham
operation (SH) after 1, 3 or 6 weeks. Functional measure-
ments and organ weights from SH animals did not change
signi¢cantly with time at 1, 3 or 6 weeks after surgery and
therefore the data were pooled to form a single SH group for
clarity. TAC caused approximately 40 mm Hg increases in
systolic aortic pressure (Fig. 1A) and LV systolic pressure
(data not shown). The pulse pressure (Fig. 1C) was increased
three-fold compared with the SH group. There was a modest
rise in mean arterial pressure (Fig. 1B). Heart rates remained
Fig. 1. Functional measurements from SH and TAC mice. Values
are meansRS.E.M. SAP, proximal systolic arterial pressure; MAP,
mean arterial pressure; PP, pulse pressure; HR, heart rates; W1^
W6, week 1^6. *P6 0.05 vs. SH group (n=7).
Fig. 2. Tissue weights from SH and TAC mice. Values are means
RS.E.M. W1^W6, week 1^6. *P6 0.05 vs. SH group (n=7).
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unchanged with time and were not signi¢cantly di¡erent from
SH mice (Fig. 1D).
Because there were no di¡erences in body weight and tibial
length between groups, the organ weights are expressed as
absolute values. TAC resulted in signi¢cant time-dependent
increases in total heart weight and LV heart weight during
weeks 1^6 (Fig. 2A,B). RV weights were not signi¢cantly al-
tered in the TAC group at weeks 1 and 3 but were about 40%
greater than in the SH group at week 6 following TAC (Fig.
2C). We have previously shown that hypertrophy of the RV
after sustained TAC occurs in response to pulmonary conges-
tion [25].
3.2. ANP mRNA expression
Myocytes were isolated from SH and TAC mice at the
times indicated and used to prepare total RNA. RNase pro-
tection analysis was used to assess the e¡ect of TAC on ex-
pression of the hypertrophy-induced marker gene ANP. ANP
mRNA levels were three-fold higher in myocytes isolated
from the LV of TAC mice compared to SH animals 3 weeks
following TAC surgery (Fig. 3A,B) and remained elevated
after 6 weeks (Fig. 3A). These results con¢rm that TAC-in-
duced LVH is accompanied by activation of ‘fetal gene pro-
gram’ markers as described by others [19].
3.3. Protein and RNA content
Since over 80% of total RNA is ribosomal, RNA content
was used as a measure of ribosome accumulation [14]. Adult
cardiomyocytes undergo only limited, if any, DNA replica-
tion, and thus DNA content was used to normalize RNA
content per cell. Myocytes were isolated from SH and TAC
mice at the times indicated and used to measure total RNA,
DNA and protein. Following quantitation, RNA to DNA
Fig. 3. Ventricular myocyte expression of ANP mRNA in SH and
TAC mice. RNA was extracted from LV myocytes isolated 3 and
6 weeks (W3, W6) after SH or TAC. RNA (1 Wg) was assayed by
RNase protection for ANP and GAPDH mRNA. A: RNase-pro-
tected bands of ANP and GAPDH were visualized by phosphori-
maging. B: Quantitative analysis of ANP mRNA expressed relative
to GAPDH mRNA. Values are meansRS.E.M. of data from ven-
tricles of SH and TAC animals at week 6. **P6 0.005 vs. SH
group (n=3).
Fig. 4. Relative RNA and protein levels in ventricular myocytes isolated from SH and TAC mice. The values expressed in Table 1 were used
to calculate the percentage ( R S.E.M., n=3^5) increase in RNA or protein content in LV or RV myocytes from TAC mice at 1, 3, and 6 weeks
(W1, W3, W6), following surgery relative to the levels in LV or RV myocytes from SH mice at week 1. A,B: Increases in myocyte RNA
to DNA ratios and protein to DNA ratios in LV-SH and LV-TAC mice. *P6 0.05, **P6 0.005, and ***P6 0.0005 vs. LV-SH at week 1.
C,D: Increases in myocyte RNA and protein levels in RV-SH and RV-TAC mice. *P6 0.05 vs. RV-SH at week 1.
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and protein to DNA ratios were determined (Table 1). RNA
to DNA ratios, and thus RNA content, were signi¢cantly
increased (168.8 R 18.2%, P6 0.005, n=3) in myocytes iso-
lated from LV of TAC mice compared to SH animals within
1 week of surgery and remained signi¢cantly elevated at 3 and
6 weeks (Fig. 4A). Total RNA content was not increased in
myocytes from RV of TAC mice compared to SH mice at
1 and 3 weeks following surgery but was increased at 6 weeks
(Fig. 4C), which correlated with the increase of RV mass that
was observed at 6 weeks. These ¢ndings suggest that rRNA
content is increased in response to pressure overload along
with tissue mass. Similarly, TAC resulted in increased protein
to DNA ratios (138.6 R 7.3%, P6 0.005, n=3), and thus pro-
tein content in LV myocytes compared to SH group 1 week
following surgery, and remained elevated at weeks 3 and 6
(Fig. 4B). Protein content was also higher in the RV from
TAC versus SH at 6 weeks (130.3 R 5.5%, P6 0.05, n=3).
These results demonstrate that TAC-induced LVH is charac-
terized by a signi¢cant increase in myocyte RNA accumula-
tion re£ecting increased rates of ribosome biogenesis, required
for the accelerated accumulation of protein.
3.4. rRNA synthesis
In cardiomyocyte cultures, an important rate-limiting step
in the accumulation of rRNA is the rate of transcription of
the rDNA [26,27]. To con¢rm that the accumulation of total
RNA was largely due to accelerated rDNA transcription
rates, we measured rRNA synthesis in myocytes using a novel
ribonuclease protection assay based on the ETS of the ribo-
somal 45S gene (Fig. 5C). The 28S, 5.8S and 18S rRNAs are
transcribed as a single pre-rRNA transcript called the 45S pre-
rRNA. Following synthesis of the 45S pre-rRNA the internal
transcribed spacer and ETS regions of the 45S pre-rRNA
transcript are rapidly processed and degraded to give rise to
the stable 28S, 5.8S and 18S rRNA. The 5P-ETS region of the
45S pre-rRNA is degraded so pro¢ciently (within minutes)
compared to 28S, 5.8S and 18S rRNA (the latter have half-
lives of several days) [9,28,29] that its accumulation can be
used to measure the steady-state level of transcription of the
45S ribosomal gene. Accordingly we prepared a riboprobe
that protects a portion of this ETS region and used it in a
ribonuclease protection assay to measure the rate of accumu-
lation of newly transcribed rRNA. Using this method, two
main protected bands are observed for the 5P-ETS RNA
(Fig. 5A) due to the presence of a major processing site within
this region of the 5P-ETS (Fig. 5C) [30]. As can be seen, rRNA
synthesis was signi¢cantly increased (2.1-fold) in myocytes
isolated from LV of TAC mice compared to SH animals
1 week after TAC (Fig. 5A,B), and remained elevated 3 and
6 weeks after TAC (data not shown). This degree of activation
is typical for the ribosomal DNA genes. Transcription of
rDNA genes is regulated in the range of 1.5^4 times under
a broad spectrum of in vivo and in vitro conditions [6,7,31^
37]. Levels of GAPDH mRNA (upper band, Fig. 5A) were
simultaneously hybridized with the 45S rDNA ETS to correct
for minor di¡erences in RNA loading.
3.5. LVH is associated with increased expression of the
ribosomal gene transcription factor UBF
The level of the rDNA transcription factor UBF was deter-
mined by Western analysis of LV and RV myocyte protein
extracts from SH and TAC mice. Equal amounts of total
protein were fractionated by SDS^PAGE, and UBF levels
Fig. 5. Synthesis of ribosomal RNA in SH and TAC mice 1 week
following surgery. RNA was extracted from LV myocytes isolated
1 week after surgery from SH and TAC mice. RNA (1 Wg) was as-
sayed by RNase protection for 45S 5P-ETS RNA and GAPDH
mRNA as described in Section 2. A: RNase-protected bands of the
5P-ETS region of the 45S gene and GAPDH were visualized by
phosphorimaging. B: Quantitative analysis of ribosomal RNA ex-
pressed relative to GAPDH mRNA. Values are meansRS.E.M.
(n=3). **P6 0.005 TAC vs. SH group. C: ETS probe used for the
RNase protection assay protects the rapidly processed 5P-end of the
45S gene (+1 to +155). Two protected fragments with a size of
V105 and V55 bp, respectively, can be detected on a denaturing
polyacrylamide gel, resulting from rapid cleavage of a site in the
5P-ETS region [30].
Table 1
Relative RNA and protein levels in ventricular myocytes isolated from SH and TAC mice
Tissue region Wg RNA/Wg DNA Wg protein/Wg DNA
SH TAC SH TAC
LV W1 0.56R 0.10 0.95R0.10** 26.13R 2.59 36.22R 1.92**
W3 0.66R 0.09 0.87R0.08* 28.42R 2.15 38.58R 3.02**
W6 0.51R 0.06 0.88R0.02*** 28.06R 1.73 35.94R 3.72*
RV W1 0.59R 0.04 0.55R0.11 24.63R 3.27 28.93R 1.41
W3 0.65R 0.03 0.61R0.09 27.85R 2.08 26.50R 1.09
W6 0.58R 0.11 0.79R0.07* 26.08R 2.03 32.09R 1.36*
RNA, protein and DNA were extracted from LV myocytes isolated 1, 3 and 6 weeks (W1, W3 and W6) after surgery from SH and TAC
mice. After quanti¢cation as described in Section 2, the RNA and protein levels were expressed relative to DNA content (Wg RNA/Wg DNA,
Wg protein/Wg DNA). *P6 0.05, **P6 0.005, and ***P6 0.0005 vs. SH group at week 1.
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were determined by immunoblotting using anti-UBF antibod-
ies. UBF exists in two forms, UBF1 and UBF2, and therefore
migrates as a doublet. UBF1/2 levels per unit of total protein
were signi¢cantly increased (2.5-fold) in LV extracts from
TAC mice compared to the LV extracts from SH mice
1 week after surgery and remained elevated at 3 and 6 weeks
(Fig. 6A,B). This level of induction is in a similar range to
that observed for isolated neonatal cardiomyocyte cultures
following hypertrophic stimuli [5,6]. Blots were stripped and
re-probed with antibodies to ERK1/2 to con¢rm equal load-
ing and quantitation of the UBF levels was normalized to the
ERK1/2 signal. It has been shown that the total amount of
cellular ERK1/2 in adult cardiomyocytes in vivo does not
change after aortic banding, as opposed to its phosphoryla-
tion state [38]. Importantly, UBF levels were signi¢cantly
higher in LV of TAC mice compared to the matched RV
from the same animal, which correlates with the faster growth
rate of LV following pressure overload (Fig. 6C). In contrast,
no signi¢cant di¡erences in UBF levels were observed between
LV and RV of SH animals (Fig. 6E,F). Interestingly, although
UBF levels were unchanged in RV extracts from TAC mice 1
and 3 weeks following surgery (Fig. 6C,D), by 6 weeks, a
small but statistically signi¢cant increase was observed (Fig.
6C), which is consistent with the observation that RNA con-
tent and weight of the RV chamber from TAC mice is also
elevated at this time point (see Figs. 2C and 4C). Taken to-
gether these results demonstrate that the increased UBF levels
correlate with the elevated pressure load and increased growth
rates and did not simply re£ect tissue or regional di¡erences in
the expression of this factor in normal hearts.
4. Discussion
The development of LVH is associated with complex phe-
notypic changes in the cardiac cell population resulting in
disturbances in cardiac electrophysiology and myocardial con-
tractile dysfunction. Although ¢brosis, cell death, prolifera-
tion and migration may all contribute to the cardiac dysfunc-
tion to some extent [39], several lines of evidence indicate that
a component of the transition to heart failure is attributable
to the increased LV mass itself [40,41]. At the cellular level,
global accumulation of protein resulting from increased rates
of protein synthesis is the primary means by which the en-
largement of myocytes and subsequent increase in LV mass
occurs. Thus, identi¢cation of the speci¢c component(s) in the
protein synthetic pathways that are perturbed during disease
states may provide clues for the design of tools or therapies
that can address the role of LV mass in heart failure.
One of the fundamental regulatory points for protein syn-
thesis is the availability of functional ribosomes. A major rate-
limiting step in the synthesis of ribosomes is rDNA transcrip-
tion. In order to identify potential regulatory mechanism(s)
for pathophysiological hypertrophy we have examined the
molecular mechanism(s) regulating rDNA transcription dur-
ing cardiac growth. Previously we identi¢ed an architectural
rDNA transcription factor, UBF, whose cellular activity is
regulated during hypertrophy of isolated neonatal cardiomyo-
cytes [5^8]. Such studies suggest that increases in UBF are at
least part of the mechanism by which rDNA transcription
rates are modulated during cardiac hypertrophy in vivo.
Such conclusions, however, assume that the molecular mech-
anism(s) that regulate the growth of isolated neonatal cultured
cells ex vivo are the same as those responsible for ribosome
biogenesis in fully di¡erentiated adult cardiomyocytes in vivo.
While this is a tempting assumption, it has been well estab-
lished that rDNA transcription rates are subject to regulation
at multiple levels and may di¡er within the same cell type
depending on the stimuli (reviewed in [14]).
In this study we show for the ¢rst time that UBF is a target
for regulation during hypertrophy of adult cardiomyocytes in
vivo. Puri¢ed myocytes isolated from LV of mice undergoing
TAC-induced LVH exhibited increased rates of rRNA syn-
thesis and expression of UBF relative to SH mice. Moreover,
UBF levels were signi¢cantly higher in LV of TAC mice com-
Fig. 6. UBF protein levels are increased in mouse LV myocytes following imposition of TAC. Myocyte protein was extracted from LV and
RV myocytes isolated 1, 3 and 6 weeks (W1, W3, and W6) after surgery from SH and TAC mice. Equal amount of protein extracts (100 Wg)
were fractionated by SDS^PAGE, transferred to nylon membranes and successively probed with an antiserum against UBF1/2 and a polyclonal
antibody against the mitogen-activated protein kinase, ERK1/2. A: A representative Western blot showing UBF and ERK expression in LV
from SH and TAC mice 1, 3, and 6 weeks following surgery. B: UBF1/2 levels in three experiments similar to that shown in A were quanti-
tated with the optical densitometry quanti¢cation software Scion Image for Windows (NIH, USA), normalized for ERK1/2 expression and ex-
pressed as the percentage increase ( R S.E.M., n=3). *P6 0.05 vs. LV-SH at W1. C: A representative Western blot showing UBF and ERK ex-
pression in LV and RV from TAC mice 1, 3, and 6 weeks following surgery. D: UBF1/2 levels in three experiments similar to that shown in
C were quantitated, normalized for ERK1/2 expression and expressed as the percentage increase ( R S.E.M., n=3). *P6 0.05, **P6 0.001. vs.
RV-TAC at W1. E: A representative Western blot showing UBF and ERK expression in LV and RV from SH mice 1, 3, and 6 weeks follow-
ing surgery. F: UBF1/2 levels in three experiments similar to that shown in E were quantitated, normalized for ERK1/2 expression and ex-
pressed as the percentage increase ( RS.E.M., n=3).
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pared with the matched RV from the same animal, which
correlates with the faster growth rate of LV following pressure
overload. Interestingly, UBF level was unchanged in myocytes
from the right ventricle 1 or 3 weeks after surgery of TAC
mice (Fig. 6), but was moderately (but signi¢cantly) higher at
6 weeks. This increase correlates with a late increase in hyper-
trophy of the RV at this time point. Thus we conclude that
up-regulation of UBF expression directly correlates with my-
ocyte hypertrophic growth in vivo and that increased expres-
sion of UBF is a conserved response to hypertrophic stimuli
between neonatal and adult myocytes and between species.
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